Aprea Therapeutics (APRE) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.72
-0.64
-0.57
-0.49

Details

Expected EPS
-0.7113
Actual EPS
-0.53
Surprise EPS
0.18
Surprise Percent
+25.49%

Description

Aprea Therapeutics (APRE) has reported earnings of -0.53 per share for Q3 2025.

0 Comments

Share your thoughts